Type 1 diabetes mellitus (T1DM) is an autoimmune condition that results in low plasma insulin levels by
destruction of beta cells of the pancreas. As part of the natural progression of this disease, some patients
regain beta cell activity transiently. This period is often referred to as the ‘honeymoon period’ or remission of
T1DM. During this period, patients manifest improved glycemic control with reduced or no use of insulin or
anti-diabetic medications. The incidence rates of remission and duration of remission is extremely variable.
Various factors seem to influence the remission rates and duration. These include but are not limited to
C-peptide level, serum bicarbonate level at the time of diagnosis, duration of T1DM symptoms, haemoglobin
A1C (HbA1C) levels at the time of diagnosis, sex, and age of the patient. Mechanism of remission is not clearly
understood. Extensive research is ongoing in regard to the possible prevention and reversal of T1DM.
However, most of the studies that showed positive results were small and uncontrolled. We present a 32-yearold
newly diagnosed T1DM patient who presented with diabetic ketoacidosis (DKA) and HbA1C of 12.7%.
She was on basal bolus insulin regimen for the first 4 months after diagnosis. Later, she stopped taking insulin
and other anti-diabetic medications due to compliance and logistical issues. Eleven months after diagnosis,
her HbA1C spontaneously improved to 5.6%. Currently (14 months after T1DM diagnosis), she is still in
complete remission, not requiring insulin therapy.
Funding
The Research Open Access Article Publishing (ROAAP) Fund of the University of Illinois at Chicago for financial support towards the open access publishing fee for this article.